Neurology Today in 5
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the latest issue.
Thu, April 17, 2025
Impact of high-dose Vitamin D on MS relapse, the role of AI in neurology education, and a 4D animal model that shows precursors of MS lesions before they appear.
In this episodeof Neurology Today in 5, Neurology Today editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a large trial that found high-dose Vitamin D reduced MRI evidence of disease activity in patients with clinically isolated syndrome or early relapsing MS; an animal brain map, revealing changes in inflammation, immune activity, and cell repair that preceded the appearance of MS lesions; and a discussion of the challenges and opportunities of using AI in neurology education.
Thu, April 03, 2025
New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants
In this week’s podcast, Neurology Today ’s editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research.
Thu, March 20, 2025
Impact of NIH cuts on neurology research, response to ACP’s guideline on migraine, an updated position on seizures, driver licensure, and medical reporting
In this week’s podcast, Neurology Today ’s editor-in-chief highlights articles on the impact of NIH cuts to indirect research costs, response to a new guideline on migraine prevention from ACP, and an updated position statement from the AAN on seizures, driver licensures, and medical reporting.
Thu, March 06, 2025
Lifetime burden of dementia, hidden features on EEGs for epilepsy detection, neurology-trained pharmacists
In this week’s podcast, Neurology Today ’s editor-in-chief highlights articles on the larger lifetime burden of dementia than projected, an AI-fueled program that detects hidden features in EEGs for epilepsy detection, and neurology-trained pharmacists who are working with neurology departments.
Thu, February 20, 2025
IVF and MS relapse, community-based neurologists doing clinical research, and the loneliness protein implicated in brain function.
In this week’s podcast, Neurology Today ’s editor-in-chief highlights articles on new data on IVF safety for women with MS, an elevated protein associated with loneliness, social isolation and brain function, and the role of community-based neurologists in drug development.
Thu, February 06, 2025
Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment
In this week’s podcast, Neurology Today ’s editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.
Thu, January 16, 2025
Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024.
In this week’s podcast, Neurology Today ’s editor-in-chief highlights articles on the safety of middle meningeal artery embolization for chronic subdural hematoma, the processed red meat and risk for dementia, and editors’ picks for the best advances of 2024.
Thu, January 02, 2025
Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players.
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the latest Cochrane review of magnesium sulfate to prevent cerebral palsy; a novel mRNA system for gene therapy for muscular dystrophies, and the perception of CTE and suicidality risk in retired NFL players.
Thu, December 19, 2024
Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty
In this week’s podcast, Neurology Today ’s editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest, the use of large language models to address administrative burden with electronic medical records, and the growth of training programs in neonatal neurocritical care.
Thu, December 05, 2024
3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration
In this week’s podcast, Neurology Today ’s editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR encephalitis, an analysis comparing the diagnostic efficacy of skin biopsies vs. CSF tests for human prion diseases, and the ways in which a graduate degree in public health and/or business administration can shape career pathways for neurologists.
Thu, November 21, 2024
Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s
In this week’s podcast, Neurology Today ’s editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure therapies on adults with epilepsy, the impact of social determinants of health on children with MS, and the status of coverage for blood-based tests for Alzheimer’s disease.
Thu, November 07, 2024
Fever prevention and stroke, environmental toxins and Parkinson’s, cholesterol overload and ALS progression
In this week’s podcast, Neurology Today ’s editor-in-chief highlights articles on fever prevention and stroke outcomes, the impact of air pollution and other environmental toxins on Parkinson’s, and the role of cholesterol overload in ALS progression and disease risk.
Thu, October 17, 2024
Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder
In this week’s podcast, Neurology Today ’s editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder. This Podcast is being Sponsored by LocumTenens.com
Thu, October 03, 2024
Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke
In this week’s podcast, Neurology Today ’s editor-in-chief highlights articles on Eastern equine encephalitis relief, systems developed to meet demand for anti-amyloid therapies, and a new protocol for timely diagnosis and treatment for eye stroke in the emergency department. This Podcast is being Sponsored by LocumTenens.com
Thu, September 19, 2024
Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s
In this week’s podcast, Neurology Today ’s editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson’s gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer’s.
Thu, September 05, 2024
Alzheimer’s diagnosis criteria, AI and Parkinson’s severity, neurotoxicity of racism
In this week’s podcast, Neurology Today’s editor-in-chief highlights a new workgroup’s recommendations on biomarkers for diagnosing Alzheimer’s, AI’s ability to track Parkinson’s severity from brief videos, and the latest research on how racism leads to neural changes and accelerated aging.
Thu, August 15, 2024
Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice
In this week’s podcast, Neurology Today ’s editor-in-chief discusses data on the association between weight loss drugs and a rare type of optic neuropathy, ethical issues around normothermic regional perfusion, and how neurologists are onboarding and training advanced practice practitioners in comorbid cancer and stroke.
Wed, July 31, 2024
Body composition and neurologic disease, Tenecteplase and stroke related-disability, comorbid stroke and cancer
In this week’s podcast, Neurology Today ’s editor-in-chief discusses data on the complex interaction between body composition, vascular health, and neurodegenerative disease, Tenecteplase in an extended treatment window and stroke-related disability, and gene expression in cormorbid cancer and stroke.
Thu, July 18, 2024
Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab
In this week’s podcast, Neurology Today ’s editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.
Thu, July 04, 2024
Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology
In this week’s podcast, Neurology Today ’s editor-in-chief discusses data on the effectiveness of rescue therapies when endovascular thrombectomy fails, how first-seizure clinics reduce hospitalizations, and AI’s use in sleep neurology.
Thu, June 20, 2024
When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data showing those with the highest composite score of inflammatory markers had a greater risk for stroke, original reporting stressing that residency programs and applicants need to adopt more strategic approaches to managing the overwhelming volume of applications. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Thu, June 06, 2024
Code for ICH, new findings on Havana syndrome, distal symmetric polyneuropathy underdiagnosed in low income primary care clinics
In this week’s podcast, Neurology Today ’s editor-in-chief discusses a push among neurocritical care experts to develop a code procedure for intracerebral hemorrhage, new findings showing people with Havana syndrome have functional neurologic disorder, and a study reporting distal symmetric polyneuropathy is more prevalent but less diagnosed in primary care clinics in low-income areas. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Thu, May 16, 2024
Surgical removal of hematoma in ICH, disparities in neurodiagnosis for epilepsy, inequities among female neurology researchers
In this week’s podcast, Neurology Today ’s editor-in-chief discusses a new study reporting better outcomes with surgical removal of hematoma in intracerebral hemorrhage, disparities in access to diagnosis and care for epilepsy, and the challenges that remain for women in neurology research.
Thu, May 02, 2024
Generative AI for personal statements, Match Day and neurology, AHS statement on CGRP-targeting therapies
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors’ response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment.
Thu, April 18, 2024
ME/CFS and long COVID; negative outcomes for ALS drug; donanemab
Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer’s disease.
Thu, April 04, 2024
BTK inhibitors for MS, lecanemab, neurologic adverse effects and COVID vaccine
Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that casts doubt on the future of BTK inhibitors for MS, an assessment of the cost-effectiveness of lecanemab, and findings that COVID vaccines are not significantly associated with adverse neurologic events.
Thu, March 21, 2024
SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens.
Thu, March 07, 2024
AI and 911 stroke detection, iatrogenic Alzheimer’s and human growth hormone, seizure dogs and refractory epilepsy
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the use of AI in EMS systems for stroke detection, the association between human growth hormone and iatrogenic Alzheimer’s, and seizure dogs for refractory epilepsy.
S24 E4 · Mon, February 12, 2024
Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.
Thu, January 25, 2024
Cerebral amyloid angiopathy and nontraumatic subdural hemorrhage, AI for neurology boards, weight loss drugs and neurologic conditions
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the cerebral amyloid angiopathy as a risk factor for nontraumatic subdural hemorrhage, AI beats humans in neurology-like boards, and the impact of popular weight loss drugs on neurologic conditions.
Tue, January 16, 2024
Rising incidence of Creutzfeldt-Jakob disease, therapy for prodromal migraine, neurotrauma of blast injury
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the rising incidence of Creutzfeldt-Jakob disease, an effective therapy for prodromal migaine, and neuroinflammation in military personnel exposed to blast injury.
Tue, January 02, 2024
DBS and cognition in severe TBI, in utero exposure to antiseizure drugs, best advances of 2023
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on the impact of deep brain stimulation on cognition in severe traumatic brain injury and how adaptive functioning is impacted in children exposed to antiseizure drugs in utero, and the editorial board’s picks for the best advances of 2023.
Thu, December 21, 2023
Parkinson’s and suicide risk; biomarkers and underrepresentation in Alzheimer’s trials, immune system changes in ALS and Parkinson’s.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing double the suicide risk among Parkinson’s patients; underrepresentation of non-White people in Alzheimer’s trial related to biomarker eligibility; early immune systems changes may play early role in ALS and Parkinson's.
Thu, December 07, 2023
Serotonin and long COVID, Afib detected 3 years after stroke, Medicare on PET amyloid scans
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing serotonin depletion associated with long COVID; implantable cardiac monitors detect Afib 3 years post-stroke; and what Medicare’s decision to cover PET amyloid scans means for neurologists.
Thu, November 16, 2023
A promising drug for refractory epilepsy; adverse childhood events and headache disorders; pathological engulfment by microglia in dementia.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on a promising potassium channel opener for refractory epilepsy; the impact of adverse childhood events in headache disorders; and excessive engulfment by microglia/astroctyes in dementia.
Thu, November 02, 2023
Blood transfusions and spontaneous intracerebral hemorrhages, long distance travel to neurologists, biomarkers for Parkinson’s disease
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on the risk of spontaneous intracerebral hemorrhages after blood transfusions; the burden of long distance travel to see neurologists; and two promising biomarkers for early diagnosis of Parkinson’s disease.
Thu, October 19, 2023
Blood pressure and endovascular therapy, cutbacks in neurology CME, blood test for Alzheimer’s
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on blood pressure targets for stroke after endovascular therapy, changing policies on CME, and a direct-to-consumer blood test for Alzheimer’s disease.
Thu, October 05, 2023
Football and Parkinson’s, deep brain stimulation for stroke recovery, neuroprostheses for anarthric patients
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on football and the risk for Parkinson’s disease, the potential of deep brain stimulation for recovery from stroke, and neuroprostheses for patients with anarthria.
Thu, September 21, 2023
Medicare coverage of carotid stenting, disparities in vulnerable neuro-oncology patients, optical EMG for neuromuscular disorders.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses the Medicare’s proposed coverage of carotid stenting in asymptomatic patients,neuro-oncologists’ perspectives on a federal initiative to target persistent poverty in vulnerable patients, and the technological promise of a new optical EMG for neuromuscular disorders.
Thu, September 07, 2023
Endovascular treatment and intracranial tumors; guideline on IVIG use for neuromuscular disorders, pros and cons of donanemab.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses research that assesses the safety of endovascular treatment post-stroke for people with intracranial tumors, the AANEM guideline on IVIG use for neuromuscular disorders, and the latest data on donanemab.
Thu, August 17, 2023
Oral health and cognitive decline; managing first-ever sleep seizures; growth of concierge neurology.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that associate poor oral health and risk for cognitive decline and how to manage first-ever sleep seizures that recur as well as the growth of concierge neurology.
Thu, August 03, 2023
Gene variants and MS severity, AI and EEG reads, neuroprotective agent for ischemic stroke
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that identify gene variants associated with MS severity/progression, an AI program that read EEGs accurately, and butylphthalide as a promising neuroprotective agent for ischemic stroke.
Thu, July 20, 2023
Antigen tolerance in mouse MS model, epileptiform activity and ICU outcomes, agent slows gliomas.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a novel therapeutic approach that induced antigen tolerance in an MS mouse model, the association between epileptiform activity and ICU outcomes, and an agent, vorasidenib, that slows low-grade gliomas.
Thu, July 06, 2023
Gout and risk of neurodegenereative diseases, Tenecteplase compared with warfarin, cognitive decline after heart attack
In this week’s podcast, Neurology Today’s editor-in-chief discusses the association between gout and neurodegenerative diseases, tenecrteplase vs.warfarin for acute stroke, expedited cognitive decline after a heart attack.
S2 Enull · Thu, June 15, 2023
Antipsychotic for dementia-related agitation, contaminated water at Camp Lejeune associated with elevated risk for Parkinson’s, gene variant confers resilience against autosomal dominant Alzheimer’s.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the FDA approval of an antipsychotic for agitation in dementia, elevated risk for Parkinson’s in Camp Lejeune Marines exposed to contaminated water, a gene variant delays the onset of symptoms in man with autosomal dominant Alzheimer’s. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Thu, June 01, 2023
OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy
In this week’s podcast, Neurology Today’s editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Thu, May 18, 2023
Assay detects Parkinson’s before symptom onset; life stressors in pregnant women with epilepsy; role of inflammation in NORSE
In this week’s podcast, Neurology Today ’s editor-in-chief discusses a new study reporting a gene assay detected Parkinson’s before symptoms onset, life stressors greatly impact women with epilepsy during pregnancy; the role of inflammation in new-onset refractory status epilepticus. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Thu, May 04, 2023
Anticoagulants for patients with dementia and Afib, tau levels in women taking hormone replace therapy, neurohumanities programs for neurology residents.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses a new study finding anticoagulants are safe for patients with atrial fibrillation and dementia, women on hormone replacement therapy had higher tau levels, and neurology residents are participants in humanities programs to foster wellness.
Thu, April 20, 2023
Fertility treatments for women with MS, stroke systems of care, ravalizumab for NMOSD
In this week’s podcast, Neurology Today ’s editor-in-chief discusses a new study finding fertility treatments did not lead to MS relapses for women, a AHA consensus statement that finds stroke systems need improvement, and ravalizumab at less frequent doses was effective for neuromyelitis optica spectrum disorder.
Thu, April 06, 2023
Intranasal CGRP for migraine, ultrasound ablation for Parkinson’s disease, novel therapeutic pathway for Duchenne muscular atrophy.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the newly approved zavegepant for migraine, the potential/caveats of ultrasound ablation for Parkinson’s disease, the transational potential of a new therapeutic target for Duchenne muscular atrophy.
Thu, March 16, 2023
Antipsychotics and dementia risk; biomarkers for lecanemab eligibility; trial of difelikefalin for neurogenic itch in notaliga paresthetica.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses the increased use of antipsychotics during the pandemic and an associated greater risk for dementia, determining the best biomarkers when considering lecanemab for Alzheimer’s, and a novel approach for managing uncomfortable neuropathic symptoms.
Thu, March 02, 2023
Pregnancy-associated stroke outcomes; a robotic device for shoulder movement in ALS; non-invasive neurostimulation for refractory seizures.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses long-term adverse outcomes from pregnancy-associated stroke, a robotic device to assist shoulder movement in ALS, and the promise of neurostimulation for refractory seizures in the ICU.
Thu, February 16, 2023
Acute infections and increased risk for dementia, alternatives to CPAP for sleep apnea; the legacy of Dr. Ralph Sacco.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses the associated risk between acute infections and dementia; alternative therapies to CPAP for sleep apnea; and Dr. Ralph Sacco’s impact on the field.
Thu, February 02, 2023
IV thrombolysis for large vessel occlusion; impact of mindfulness, exercise on cognition;new brain layer in subarachnoid space.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the report on outcomes of IV thrombolysis for large vessel occlusions; the discovery of a new brain layer in the subarachnoid space; and the impact of mindfulness and exercise on cognition.
Thu, January 19, 2023
Best advances of 2022, misdiagnosed autoimmune encephalitis, inflation his neurology private practice
In this week’s podcast, Neurology Today ’s editor-in-chief discusses the report on misdiagnosis of autoimmune encephalitis, inflationary times for neurologists in private practice, and the editorial board picks for best advances in 2022.
Wed, January 04, 2023
Spinal cord stimulation for chronic pain, disparities in brain age by race/ethnicity, careers in teleneurology
In this week’s podcast, Neurology Today ’s editor-in-chief discusses a comparison of spinal cord stimulation with medical management for chronic pain, earlier brain aging in Black people, and the pros/cons of working for teleneurology companies.
Thu, December 15, 2022
Rituximab for MS, food security and cognition, in utero treatment for Pompe disease
In this week’s podcast, Neurology Today ’s editor-in-chief discusses why MS specialists advocate for rituximab for MS, how food security may relate to cognition, and a novel in utero therapy for Pompe diseasea.
Thu, December 01, 2022
Modifiable risk factors for monogenic stroke, health care systems prepare for wave of new Alzheimer’s therapies, criteria for selecting neurology residents
In this week’s podcast, Neurology Today ’s editor-in-chief discusses modifiable risk factors for monogenic stroke, what health care systems need to do to prepare for new Alzheimer’s therapies, and criteria program directors apply in selecting neurology residents.
Thu, November 17, 2022
Revascular therapies for stroke patients with COVID, dementia and suicide risk, hyperbaric oxygen therapy for concussion in children.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses data suggesting revascular therapies are safe for patients with stroke and COVID, dementia is associated with increased suicide risk, and the potential of hyperbaric oxygen therapy for children with concussion.
Thu, November 03, 2022
Allergies and dementia risk, folic acid and risk of cancer in children of women with epilepsy, climate change and neurologic disorders.
In this week’s podcast, Neurology Today’s editor-in-chief discusses data suggesting allergic disease is associated with an increased risk of dementia, an increased risk of cancer in children born to women with epilepsy who took high-dose folic acid in pregnancy, and the impact of climate change on people with neurologic disorders.
Thu, October 20, 2022
Vamorolone for DMD, aquaporin protein and amyloid clearance, monkey pox-associated neurologic events.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses data suggesting vamorolone as an alternative to corticosteroids for Duchenne muscular dystrophy, how an aquaporin protein promotes amyloid clearance, and neurologic events associated with monkeypox virus.
Thu, October 06, 2022
Chronic kidney disease and risk for intracerebral hemorrhage, gonadotropic replacement and cogntion in Down syndrome, how to distinguish polio from other viruses
In this week’s podcast, Neurology Today ’s editor-in-chief discusses new findings on chronic kidney disease and risk for intracerebral hemorrhage, the potential of gonadotropic replacement for improving cognition in Down syndrome, and distinguishing polio from acute flaccid myelitis and other viruses.
Thu, September 15, 2022
Decompression and Chiari malformation, atrial cardiopathy and dementia risk, 3D printing the brain.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses new findings on decompression for Chiari malformation, the association of atrial cardiopathy with dementia, and a neurology resident’s 3D printing of brain model.
Thu, September 01, 2022
Processed foods and dementia risk, therapies for vertigo, impostor syndrome
In this week’s podcast, Neurology Today ’s editor-in-chief discusses the increased associated risk between processed foods and dementia risk, antihistamines vs. benzodiazepines for vertigo, and impostor syndrome in neurology.
Thu, August 18, 2022
Spinal cord stimulation for diabetic neuropathy, Roe v. Wade reversal, diversifying the neurology pipeline.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses spinal cord stimulation for painful diabetic neuropathy, the Roe v. Wade reversal and neurology, and initiatives to diversify the neurology pipeline.
Thu, August 04, 2022
Functional neurologic disorder, newborn screening for SMA, when to leave job
In this week’s podcast, Neurology Today ’s editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.
Thu, July 21, 2022
Brain aneurysm rupture, COVID-19 exposure in utero, socioeconomics and brain development.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses RAAS inhibitors for brain aneurysm rupture, the impact of COVID-19 on babies exposed in utero, and how socioeconomic status, independent of genetics, affects brain development.
Thu, July 07, 2022
Monkeypox, soticelstat for epilepsy, gabapentin for stroke recovery.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses what’s known about monkeypox, soticelstat as a potential new epilepsy therapy, and the potential of gabapentin for stroke recovery.
Thu, June 16, 2022
Fenfluramine for LGS, social isolation and dementia risk, neurology’s status in NRMP match.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses the approval of fenfluramine for Lennox-Gastaut syndrome, how social isolation affects dementia risk, and the competitiveness of neurology in this year’s residency match.
Thu, June 02, 2022
Teleneurology in rural America, trauma-informed neurology,advances in neurogenetics
In this week’s podcast, Neurology Today ’s editor-in-chief discusses the challenges and opportunities of teleneurology in rural areas, the effect of childhood trauma on neurologic disorders, and genetics advances in neurology.
Thu, May 19, 2022
Portable MRI for stroke, SSRIs and seizure risk in neonates, neurology training in Ukraine.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses portable low field MRI for stroke, SSRI exposure in pregnancy and risk for seizures in neonates, and disrupted neurology training in Ukraine.
Thu, May 05, 2022
Blood pressure trajectories, Parkinson’s risk factors, neurology residents, Potamkin Award
In this week’s podcast, Neurology Today ’s editor-in-chief discusses the link between blood pressure trajectories in young adults and cerebral lesions in midlife, early risk factors for Parkinson’s, a newly matched neurology resident, and the winner of the Potamkin Award.
Thu, April 21, 2022
Gabapentin as a controlled substance embolic stroke of undetermined source, how to become a clinician educator
In this week’s podcast, Neurology Today ’s editor-in-chief discusses the pros/cons of gabapentin as a controlled substance, recurrent stroke risk in adults with embolic stroke of unknown source, how to become a clinician educator.
Thu, April 07, 2022
Neurologists in Ukraine, neurology costs discussions, statins and parkinsonism
In this week’s podcast, Neurology Today ’s editor-in-chief discusses the link between statins and parkinsonism, how neurologists in Ukraine are faring, why and how to discuss the costs of care with patients.
Thu, March 17, 2022
New Parkinson’s therapies, antiseizure drugs in pregnancy, endovascular therapy for large core stroke
In this week’s podcast, Neurology Today ’s editor-in-chief discusses how Parkinson’s experts choose among the many new and older therapies; decline of antiseizure drug levels in pregnancy, and benefits of endovascular therapy for large core stroke.
Thu, March 03, 2022
Parkinson’s in women, gene therapy for LGMD, advance for severe SCI
In this week’s podcast, Neurology Today ’s editor-in-chief discusses a call to action to address unmet needs of women with Parkinson’s; a promising advance for people with severe spinal cord injuries, and a novel gene therapy for limb girdle muscular dystrophy.
Thu, February 17, 2022
Gender Bias in Medicare Criteria for Sleep Apnea and More
In this week’s podcast, Neurology Today ’s editor-in-chief discusses gender bias in Medicare criteria for sleep apnea; delayed cerebral ischemia with cannabis use; and income disparities between male and female neurologists, and more!
Thu, February 03, 2022
February 3-Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the February 3, 2022 issue.
Fri, January 21, 2022
January 20- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the January 20, 2022 issue.
Thu, January 06, 2022
January 6- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the January 6, 2022 issue
Fri, December 17, 2021
December 16- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the December 16, 2021 issue.
Fri, December 03, 2021
December 2- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the December 2, 2021 issue.
Fri, November 19, 2021
November 18 - Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 18, 2021 issue.
Mon, November 08, 2021
November 4- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 4, 2021 issue.
Thu, October 21, 2021
October 21- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 21, 2021 issue.
Thu, October 07, 2021
October 7- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 7, 2021 issue.
Thu, September 16, 2021
September 16- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the September 16, 2021 issue.
Sat, September 04, 2021
September 2- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the September 2, 2021 issue.
Tue, August 24, 2021
August 19- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the August 19, 2021 issue.
Thu, August 05, 2021
August 5- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the August 5, 2021 issue.
Thu, July 22, 2021
July 22- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the July 22, 2021 issue.
Fri, July 09, 2021
July 8- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the July 8, 2021 issue.
Thu, June 17, 2021
June 17- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the June 17, 2021 issue.
Thu, June 03, 2021
June 3- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the June 3, 2021 issue.
Wed, May 19, 2021
May 20- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the May 20, 2021 issue.
Thu, May 06, 2021
May 6- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the May 6, 2021 issue.
Thu, April 15, 2021
April 15- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the April 15, 2021 issue.
Wed, March 31, 2021
April 1- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the April 1, 2021 issue.
Thu, March 04, 2021
March 4- Issue Introduction
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the March 4, 2021 issue.
loading...